Back
Keros Therapeutics Vs. Axsome Therapeutics Industry Stock Comparison
Sell
14
KROS
Keros Therapeutics
Last Price:
$13.56
Seasonality Move:
5.46%
Sell
44
AXSM
Axsome Therapeutics
Last Price:
$104.13
Seasonality Move:
16.47%
Sell
14
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $13.56. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $104.10. The Score for AXSM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $13.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $104.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 42.72 | Sell |
Chaikin Money Flow: | -45350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.69 - 14.65) | Sell |
Bollinger Bands (100): | (10.75 - 13.99) | Buy |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 41.87 | Sell |
Chaikin Money Flow: | -283019 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.65 - 109.53) | Sell |
Bollinger Bands (100): | (102.31 - 122.85) | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.23 | Sell |
20-day SMA: | 14.28 | Sell |
50-day SMA: | 13.64 | Sell |
200-day SMA: | 30.03 | Sell |
8-day EMA: | 14.01 | Sell |
20-day EMA: | 14.13 | Sell |
50-day EMA: | 13.97 | Sell |
200-day EMA: | 24.87 | Sell |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 108.62 | Sell |
20-day SMA: | 107.14 | Sell |
50-day SMA: | 106.34 | Sell |
200-day SMA: | 101.89 | Buy |
8-day EMA: | 107.4 | Sell |
20-day EMA: | 107.6 | Sell |
50-day EMA: | 108.42 | Sell |
200-day EMA: | 102.21 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.03 per share, an increase this year of $4.50 per share, and a decrease next year of $4.46 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, an increase next quarter of $0.96 per share, an increase this year of $1.65 per share, and an increase next year of $5.09 per share.
Keros Therapeutics Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |